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Abstract 
Purpose: To investigate early functional changes of local retinal defects in type II 
diabetic patients using the global flash multifocal electroretinogram (MOFO mfERG). 
Methods: Thirty-eight diabetic patients and 14 age-matched controls were recruited. 
Nine of the diabetics were free from diabetic retinopathy (DR), while the remainder 
had mild to moderate non-proliferative diabetic retinopathy. The MOFO mfERG was 
performed at high (98%) and low (46%) contrast levels. MfERG responses were 
grouped into 35 regions for comparison with DR classification at those locations. 
Z-scores of the regional mfERG responses were compared across different types of 
DR defects. 
Results: The mfERG waveform consisted of the direct component (DC) and the 
induced component (IC). Local reduction in DC and IC amplitudes were found in 
diabetic patients with and without DR. With increasing severity of retinopathy, there 
was a further deterioration in amplitude of both components. Under MOFO mfERG 
paradigm, amplitude was a useful screening parameter. 
Conclusion: The MOFO mfERG can help in detecting early functional anomalies 
before the appearance of visible signs, and may assist in monitoring further functional 
deterioration in diabetic patients. 
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Introduction 
Diabetes mellitus (DM) is a group of metabolic diseases which lead to systemic 
hyperglycemia. Type I DM is caused by beta-cell destruction in the pancreas, which is 
often mediated by the immune system, and results in a loss of insulin secretion and 
absolute insulin deficiency. Type II DM is caused by a combination of genetic and 
non-genetic factors which result in insulin resistance and deficiency. Type II DM 
accounts for about 90% of cases of diabetes [1]. It is estimated that the prevalence of 
diabetes will double to 366 million worldwide by 2030; many of these patients will be 
over 65 years of age [2]. DM can impair ocular capillary perfusion, and thus lead to 
the development of diabetic retinopathy (DR).  
DR is the most frequent cause of new cases of blindness among the working 
population [3]. In the first two decades after diagnosis of the disease, over half of the 
patients with Type II DM have retinopathy [4, 5]. Diabetic patients are assessed using 
ophthalmoscopy and fundus photography [4, 6]. The main focus is to detect visible 
sign of vascular retinopathy in order to monitor progress of DR and to avoid its 
sight-threatening complications [5, 7]; however the basis of functional changes in the 
retina, especially in the early stages, has not been determined.  
The Ganzfeld full-field electroretinogram has been used to study retinal functional 
changes in diabetic patients [8-11]. The defects of DR are not distributed uniformly 
across the retina, and show a range of stages of development [12]. The full-field 
electroretinogram, which is a summated retinal response measurement, is not likely to 
reflect local or eccentric functional changes in diabetes. The multifocal 
electroretinogram (mfERG), however, provides objective topographical 
measurements of retinal responses across the visual field [13]. Palmowski et al. [14] 
and Shimada et al. [15] examined retinal function in diabetes using the mfERG; 
responses were either grouped into rings or quadrants, or summed across the retina. 
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Such groupings lose the fine topographic details in studying various types of vascular 
defect [16, 17]. Bearse et al. applied slow flash mfERG to study local oscillatory 
potentials in the diabetic retina, and suggested that retinal adaptation was more likely 
to be abnormal at sites with early retinopathy [17]. Bronson-Castain et al. and Fortune 
et al. applied the conventional mfERG to the diabetic retina, and observed an implicit 
time delay increasing with the severity of retinopathy. However, local response 
amplitudes failed to show a consistent relationship with retinal abnormalities in 
diabetic eyes [16, 18]. 
Sutter and Bearse have proposed a modified mfERG protocol, named the global flash 
mfERG, to study retinal adaptive effects. It has been suggested that the retinal 
adaptive response would be enhanced by inserting a periodic full field (global) flash 
between successive m-sequence focal flashes [19-21]. In the global flash mfERG, 
there are two main components (Fig. 1): the direct component (DC) arises 
predominantly from bipolar and N-methyl-D-aspartic-acid (NMDA)-sensitive cells; 
the induced component (IC) is predominantly from NMDA-sensitive cells and 
ganglion cells from the inner retina [22]. This global flash mfERG allows separate 
examination of the response from the outer and inner retina. In addition, Hood and 
co-workers found that nonlinear retinal responses are saturated at high contrast levels, 
and they suggested that low contrast stimuli would enhance the inner retinal response 
[20]. 
The aim of this study was to investigate the early local functional changes in diabetic 
retina at both high (98%) and low (46%) contrast levels. The use of the periodic 
global flash multifocal electroretinogram (MOFO mfERG) in diabetic patients 
assisted in correlating the local functional changes with retinopathy, and in 
investigating the depth of retinal dysfunction in diabetic patients. 
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Methods 
Subjects 
Thirty-eight type II diabetic patients were examined: 9 (aged 49.7  6.4years) did not 
have diabetic retinopathy (DR) while 29 (aged 49.8  6.4years) had non-proliferative 
diabetic retinopathy (NPDR). Fourteen control subjects (aged 49.4  7.0years) were 
also examined. All subjects had visual acuities better than 6/9. Their refractive errors 
were between +3.00 and -6.00 D, and astigmatism was less than -1.25 D. None had 
any clinically significant ocular or systemic disorders other than DR or DM. The 
plasma glucose level of the subjects was measured during the visit using a blood 
glucose meter (Accu-Chek Compact Plus, F. Hoffmann-La Roche Ltd, Basel, 
Switzerland) at least 2 hours after any food intake. Ten healthy controls and 36 
diabetic patients consented to plasma glucose measurements. The duration of DM was 
based on patient’s own report, and was represented by an ordinal parameter (DM 
diagnosed less than 5 years, DM diagnosed for 5 to 10 years, DM diagnosed for more 
than 10 years). 
All procedures of the study followed the tenets of the Declaration of Hesinki. This 
study was approved by the Ethics Committee of The Hong Kong Polytechnic 
University. Informed consent was obtained from each subject following full 
explanation of the experimental procedures. 
 
Stimulus conditions 
The VERIS Science 5.1 system (Electro-Diagnostic-Imaging, San Mateo, CA, USA) 
was used for mfERG measurement. The stimulus was shown on a high luminance 
CRT monitor (FIMI Medical Electrical Equipment, Saronno, Italy). The stimulus 
pattern contained 103 scaled hexagons with an angular subtense of 44 vertically and 
47 horizontally. The sequence of hexagonal pattern stimulation followed a 
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pseudo-random binary m-sequence (213-1) with a video frame rate of 75Hz. In each 
MOFO stimulation, there were four video frames: a pseudo-random m-sequence focal 
flash, followed by a full-screen dark frame, a full-screen global flash, and another 
full-screen dark frame. The duration of one MOFO stimulation sequence was 53.3ms. 
The background luminance of the mfERG display was 100cd/m2. At the high contrast 
level (98%), both the luminance of the bright phase of the multifocal stimulus and the 
global flashes were set at 200cd/m2 as suggested by our previous study, in order to 
obtain optimal DC and IC responses [23]. The dark phase was set at a luminance of 
2cd/m2. At the low contrast level (46%), the bright phase of the multifocal stimulus 
was set at 166cd/m2, while the dark phase was set at 61cd/m2. A central cross on the 
stimulus pattern was used as a fixation target. One eye was randomly selected for 
mfERG measurement. The recording was carried out with room illuminance of about 
100lux. 
 
Recording conditions 
Detailed eye examination (including subjective refraction, biomicroscopy and indirect 
ophthalmoscopy) with fundus photodocumentation was carried out for each subject. 
The Stratus optical coherence tomography (Carl Zeiss Meditec, Inc., Dublin, CA, 
USA) was used to measure the macular thickness in a fast scanning mode in order to 
rule out any patients with macular oedema. In the MOFO mfERG measurement, the 
pupil of the tested eye was dilated with 1% tropicamide (Alcon, Fort Worth, TX, USA) 
to at least 7mm diameter. The untested eye was occluded. A Dawson-Trick-Litzkow 
(DTL) electrode was placed on the lower bulbar conjunctiva to be the active electrode. 
Gold-cup electrodes were used as reference and ground electrodes, on the temporal 
side of the tested eye and forehead respectively. The ERG signal was amplified 
(x100,000) (Grass Instrument Co., Quincy, MA, USA) and band-pass filtered 
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(3-300Hz). The MOFO mfERG protocol was carried out at high (98%) and low (46%) 
contrast levels. The mfERG recording time for each contrast level was about 8 
minutes, and was divided into 32 segments. Each segment lasted approximately 14 
seconds, and a short break was provided between segments. The refractive error of the 
tested eye was corrected for the viewing distance of 33cm. The recording quality was 
monitored using the real time display of the VERIS program. Segments contaminated 
by poor fixation, eye movement or blinks were rejected and re-recorded immediately. 
 
Analysis 
1)  Analysis of the MOFO mfERG signals 
The 103 MOFO mfERG trace arrays were grouped into 35 regions as suggested by 
Bearse and colleagues. This grouping combines similar waveforms while maintaining 
their nasal, temporal and eccentricity locations (Fig. 2) [17, 24]. For each region, 
signal amplitudes of the DC and IC were measured. The DC implicit time was 
measured from the onset of the multifocal stimulus to the peak of DC; the IC implicit 
time was measured from the onset of the global flash to the peak of IC (Fig. 1). 
Left-eye MOFO mfERG signals were transposed so that all eyes were apparently right 
eyes for the purposes of data analysis. 
The MOFO mfERG responses from the 35 regions were grouped according to the 
fundus photographs grading (see below) for further analysis. To account for the 
topographic asymmetry of the mfERG and provide the same baseline for comparison, 
a z-score scale was established for the MOFO mfERG responses [25, 26]. The MOFO 
mfERG responses in the control group were used to calculate the means and standard 
deviations for each specific location across the 35-division of the mfERG topography. 
The means and standard deviations obtained above were then used to calculate the 
z-score of the MOFO mfERG responses for each subject at that specific region (by 
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subtracting the mean from the individual mfERG response and then dividing it by the 
standard deviation obtained from the control group, [i.e. (Individual mfERG response- 
mfERG mean response of the control group)/ standard deviation].  
 
2) Relating the plasma glucose level, DM duration, and averaged mfERG responses 
in the control and diabetic subjects 
The plasma glucose level was compared between the control and diabetic subjects by 
independent t-test. The MOFO mfERG responses from the 35-division array were 
averaged so that each subject gave a mean z-score of the mfERG responses. The 
correlation between the individual plasma glucose level and DM duration with the 
averaged mfERG responses of the diabetic subjects was then obtained. 
 
3) Grading of the fundus photographs 
A Topcon IMAGEnet Fundus camera was used to take colour fundus photographs 
with one central 45° field and eight peripheral surrounding fields. The fundus 
photographs from various fields were grouped into a single photograph in mosaic 
format. The 103 hexagonal pattern of the mfERG topography was aligned with the 
mosaic of fundus photos for each subject. The blind spot depression and the central 
peak were aligned with the optic disc and fovea respectively. The 103 hexagons were 
then grouped into the 35-division pattern as shown in Fig. 2. (Calculations including 
the range of corrections used in these experiments and the range of axial lengths 
expected suggest that the variation in magnification of the retinal image of the 
stimulus pattern would be small, in the range of 3%).  
The regional retinal defects were then graded by a masked retinal specialist according 
to the following scales based on the severity of retinopathy:  
Group 0: regional samples from control subjects 
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Group 1: regional samples from DM patients without retinopathy (“No NPDR” group) 
(equivalent up to the ETDRS level 10) [27, 28] 
Group 2: regional samples containing hard exudates (“HE” group) (equivalent up to 
the ETDRS level 14) [27, 28] 
For the regional samples with definite haemorrhage (equivalent up to the ETDRS 
level 35 and 43) [27, 28], they were further divided into two types (outer and inner 
retinal haemorrhage) based on the retinal depth of the haemorrhage.  
Group 3: regional samples containing outer retinal haemorrhage – Dot/ Blot 
haemorrhage, together with or without hard exudates (“Outer retinal haemorrhage +/- 
HE” group) 
Group 4: regional samples containing inner retinal defect – Flame haemorrhage, 
together with or without cotton-wool-spots (“Inner +/- Outer retinal haemorrhage +/- 
CWS +/- HE” group)  
(Note that retinal regions with small drusen and the retinal regions lacking retinopathy 
signs from the NPDR groups were excluded). 
 
4) Mapping between fundus photographs and MOFO mfERG topography 
Based on the above grading in the 35 retinal regions, the corresponding regional 
MOFO mfERG responses were then associated with these different retinal defect 
grades for multiple comparisons. It was assumed that the mfERG 35 divisions were 
independent of each other [16]. The statistical analysis was done using SPSS 16.0 
(SPSS, Chicago IL). Repeated measures Analysis of Variance with Bonferroni's 
adjustment was applied to study the group difference (Group 0 to 4). The Bonferroni’s 
adjustment was based on the contrast levels (a within-subject factor with two levels) 
and retinal defect groups (a between-subject factor with five levels). In the case of the 
existence of interaction between factors, simple effect of the group factor was then 
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reported.  
 
5) Evaluation of the diagnostic values of the MOFO mfERG parameters 
For each MOFO mfERG parameter (amplitude and implicit time of the DC and IC) at 
each contrast level, a receiver-operating-characteristic curve was constructed and the 
area-under-the-curve was calculated (GraphPad Prism 5; GraphPad, San Diego, CA, 
USA) to estimate the predictive ability of each parameter in DR. 
 
Results 
Correlation of the plasma glucose level and DM duration with the averaged MOFO 
mfERG parameters 
The plasma glucose levels of the diabetic subjects were significantly higher than those 
of the control subjects (independent t-test, p<0.0001). Among the 38 diabetic subjects, 
no significant correlation was found between the averaged MOFO mfERG responses 
and the DM duration (Spearman’s r ranged from -0.09 to 0.1, p ranged from 0.57 to 
0.94). For the plasma glucose level measured from the 36 diabetic subjects, 
significant correlation was only found with the mean z-score of IC implicit time at 
low contrast level. The higher the plasma glucose level was, the greater was the delay 
of the mean IC implicit time at low contrast level (Pearson’s r=0.412; p=0.012) (Table 
1). 
 
Local MOFO mfERG responses in different types of retinopathy defects 
A total of 1019 MOFO regional samples was collected. The numbers of regional 
samples from each group were: Group 0 – 486 regional samples (47.7%), Group 1- 
302 regional samples (29.6%), Group 2 – 28 regional samples (2.8%), Group 3 – 168 
regional samples (16.5%), Group 4 – 35 regional samples (3.4%). 
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DC and IC amplitude measures, and DC and IC implicit time measures, showed 
statistically significant effects of contrast levels (repeated measures ANOVA, 
p<0.001), groups (p<0.001) and their interaction (p<0.001). The differences between 
the subgroups of subjects were further studied by applying one-way ANOVA and 
Bonferroni’s post-hoc test. 
 
DC amplitude z-score (DCA_z) 
There were significantly smaller DC amplitudes at high and low contrast levels for all 
diabetic groups than for the control subjects (p<0.02) (Fig. 3). At the low contrast 
level, the DC amplitude showed a greater decrease in the presence of retinopathy 
signs. The DCA_z from the regions in group 4 deteriorated even more compared to 
the regional samples from group 1 (p=0.011) (Fig. 3). It should be noted that the 
diabetic subjects showed considerable variation in response. 
 
IC amplitude z-score (ICA_z) 
At the high contrast level (Fig. 4), all the diabetic groups (groups 1-4) showed a 
reduction in ICA_z compared to group 0 (p<0.001). With the presence of visible 
retinopathy, there was a further reduction in IC amplitude. Among the diabetic groups, 
the ICA_z of group 2 was significantly reduced compared to group 1 (p=0.0034) and 
Group 3 (p=0.018). 
At the low contrast level (Fig. 4), the trend of the ICA_z was similar to that at the 
high contrast level. Again, with the existence of visible retinopathy, there was a 
further reduction in IC amplitude. However, statistical significance was only seen 
between these two pairs of comparison: group 0 and group 2, group 0 and group 3 
(p<0.02). The ICA_z of group 3 was also significantly smaller than group 1 
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(p<0.00023). The lack of statistically significant findings between the “No NPDR” 
and control groups here may be attributed to the considerable variation in response. 
 
DC implicit time z-score (DCIT_z) 
For high contrast level stimuli (Fig. 5), all the locations with retinopathy (groups 2 – 4) 
showed a significant delay in response compared to group 0 (p<0.002) and group 1 
(p<0.01). The existence of visible retinopathy led to a greater delay in the DC implicit 
time than the regions without retinopathy. However, no statistically significant 
difference was seen for the regional samples at low contrast level. This was largely 
due to the increased variability of the responses in the DR groups, with a few patients 
showing very much faster responses, especially to the low contrast stimuli (Fig. 5). 
 
IC implicit time z-score (ICIT_z) 
At the high contrast level (Fig. 6), the mfERG responses from the diabetic groups 
were, on average, slower than those from group 0. With visible retinopathy (groups 
2-4), the delay was larger than those without DR (group 1). Group 2 and group 3 
showed a significant delay compared to group 0 in the IC implicit time (p<0.02). The 
IC implicit time of group 3 also had a significant delay in response compared to group 
1 (p=0.0022). 
At the low contrast level (Fig. 6), only group 1 showed a significant delay in IC 
implicit time compared to group 0 (p=0.0013). 
 
Diagnostic value of the MOFO mfERG parameters 
In order to determine the diagnostic value of the MOFO mfERG parameters, receiver 
operating characteristics (ROC) curves were plotted and the area-under-the-curve 
(AUC) was calculated; these values are summarized in Table 2. When differentiating 
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the retinopathy groups (groups 2-4) from group 0, DCIT_z at 98% contrast level 
resulted in the highest AUC (76.6%). However, the AUC value of DCIT_z declined to 
62.6% if it was used to differentiate the diabetic groups (groups 1-4) from group 0 
(Table 2). 
DCA_z at low and high contrast levels and the ICA_z at high contrast level showed 
the highest potential for screening out functional defects due to diabetes (including 
those without visible vascular defects) having AUC values ranging from 69.1 to 
70.9% (Table 2). 
 
Discussion 
This study illustrated the variations of MOFO mfERG responses under high (98%) 
and low (46%) contrast levels in the diabetic retina. By inserting a periodic global 
flash between two successive multifocal stimuli, adaptation activity in the retina 
should be enhanced [21]. In MOFO mfERG assessment, there are two main 
components: the direct component (DC) and the induced component (IC). The DC 
response is the average response to the focal stimulation, while the IC response shows 
the effect of the preceding focal stimulation on the response to the global flash [15]. 
In this study, using the high-contrast MOFO paradigm, the delay and reduction of the 
mfERG responses suggests that both middle and inner retinal layers (i.e. DC and IC 
responses respectively) were impaired even in diabetic patients without signs of 
retinopathy. Greater delay of response (on average) and reduction of response 
amplitude in the mfERG were seen when retinopathy signs were present. This implies 
that certain local functional deterioration started before the visible signs of vascular 
retinopathy could be detected in the clinical screening assessment. 
Previous studies have reported reduced responses in DR in the pattern ERG [29], the 
second order kernel responses of mfERG [14], the oscillatory potentials (OPs) and 
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photopic negative responses (PhNR) of the standard full-field ERG [10, 30-33] and 
mfERG [17, 34-36]. All these previous studies proposed the inner retinal functions 
were affected in diabetic retina. In the animal study, by pharmacological dissection, 
the IC was found to be contributed from the third-order neurons and ganglion cells 
[22]. The reduction of IC response here further supported the functional changes in 
the inner retina of the diabetic patients in the localized aspect. However, such 
situation was not observed in the study by Shimada et al. [15] It might be due to the 
difference in the subject inclusion. In their study, both type I and II diabetic patients 
were put together for analysis, while only type II diabetic patients were recruited in 
our current study. 
The DC in MOFO mfERG was found to be predominantly from the bipolar cells with 
partial contribution from the third-order neurons [22]. Its amplitude reduction among 
diabetic patients before observable vascular lesions in this study suggests that the 
middle retinal layers may deteriorate early in DR. Shimada et al. [15] reported similar 
findings for the high contrast mfERG. Considering the minimum oxygen supply 
appears at the area near the inner nuclear layer (INL) [37], our results agree with the 
hypothesis that the middle retina is at risk of hypoxic damage in diabetic patients. 
The reductions in the DC and IC responses provide crucial evidence that the middle 
and inner retina are actually impaired at an early stage in diabetic patients. Recent 
studies have reported that hypoxia can affect the photoreceptors and the INL [37-41], 
while excito-toxicity also plays a role in affecting the neurotransmission among 
amacrine and glial cells in the diabetic retina [42-44]. It seems that multiple retinal 
layers are affected in diabetes at the early stage [45]. Here in this study, low-contrast 
MOFO mfERG stimulation was applied to avoid saturation of the non-linear retinal 
response. Hood and co-workers [20] reported that mfERG stimulation at a contrast 
level of 50% evokes a waveform with more involvement of the inner human retina 
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[21, 46]. The low-contrast mfERG stimulus has been used to investigate inner retinal 
activity in glaucoma [47, 48]. Our diabetic patients demonstrated reduced DC and IC 
amplitudes in both high- and low-contrast conditions. However, reducing contrast of 
the stimulus does not appear to improve discrimination between the control and 
diabetic patients, and additional delay of implicit time for low-contrast stimuli was 
not obvious; this might be due to a large inter-subject variability or, more likely, the 
problems in the inner retina induced by DR are different from those induced by 
glaucoma. Since amplitude and implicit time responses under different contrast levels 
appear to be different in diabetic and glaucoma conditions [47, 48], the basis of these 
two diseases is believed to be different (e.g. cell loss or cellular dysfunction). It 
further supports the hypothesis by Greenstein and co-workers [45] that the mechanism 
of the retinal dysfunction at the early stage of DM is unlike that of glaucoma. 
Previous mfERG studies reported that the implicit time was a more “sensitive” 
parameter in detecting functional anomalies than response amplitude in DM patients 
[16, 34, 49-51]. In our study, the implicit time of DC was only maximally sensitive in 
screening retinal locations with retinopathy signs with delayed response in average. 
However, some very fast responses were obtained from the diabetic patients 
especially at the low-contrast condition. This could not be fully explained by the 
range of plasma glucose levels among subjects as there was no significant correlation 
with the DCIT. Moreover, Klemp and co-workers [52] found that the short-term 
hyperglycemia leads to a shorter implicit time in the first- and second-order mfERG 
responses, presumably because of increased retinal metabolism. This seems to 
contradict to the positive correlation here between the plasma glucose level and the 
ICIT_z at low-contrast level. The discrepancy may be due to the effect of chronic 
instead of short-term hyperglycemia in our diabetic subjects. Study on the effect of the 
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stability of the plasma glucose level (e.g. glycated hemogloblin) in type II diabetic 
patients should also be considered.  
Based on our current findings, to screen out functional abnormalities at a very early 
stage in the diabetic patients without retinopathy, the amplitudes of IC from high 
contrast stimuli, and DC at both high- and low-contrast levels were preferred. 
Compared with the longitudinal study by Harrison and co-authors [51] which showed 
the implicit time as a more sensitive parameter than amplitude, different possibilities 
may account for our difference from the previous studies:  
1) The MOFO paradigm dissociates the original mfERG retinal responses into two 
different components. The MOFO mfERG with the insertion of a global flash is used 
to enhance the retinal adaptation mechanism. By splitting the retinal components, 
subtle changes in the waveform amplitude may thus become more obvious.  
2) Modifying the electrophysiological protocols may favor the activities of different 
types of retinal cells [23, 43, 53]. The mfERG protocol used in the study by Harrison 
et al. [51] was the standard mfERG. Without the dissociation of the inner retinal 
responses by the global flash, the standard mfERG responses would mix the middle 
and inner retinal responses together; some subtle changes on the resultant waveform 
might thus be masked. And the bandpass filter applied in the study by Harrison et al. 
was 10-100Hz, which screened out some high-frequency oscillatory potentials 
contributed from the retinal ganglion cells and third-order neurons [54]; while in our 
study, a bandpass filter of 3-300Hz was applied to cover the range of both high- and 
low-frequency retinal responses, to study the middle and inner retinal layer 
performance. The involvement of the high-frequency component would thus lead to 
the difference. 
3) In our study, only type II diabetic patients were recruited, while both type I and II 
diabetic patients were recruited in the study by Harrison et al. The different subject 
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pool may cause this discrepancy. It is because the underlying mechanism, medical 
treatment, and prevalence of DR progression of type I and type II DM showed 
different patterns [1, 4, 42].  
The MOFO mfERG paradigm provides more detailed information in terms of the 
retinal adaptive changes or the retinal recovery rate than the conventional paradigm. 
However, as this study was limited by its cross-sectional nature, a longitudinal 
follow-up study should be carried out in order to find out the prediction ability of the 
MOFO mfERG for the DR onset. It is surprising that the duration of DM does not 
correlate with the individual mean MOFO responses, but this may be due to the 
variability of the latent period before DM was diagnosed for our patients. 
The multifocal electroretinogram, together with the MOFO paradigm, provides a 
means of detecting early functional anomalies in the diabetic retina before visible 
vascular defects appear. Comparing with the other standard electrophysiological 
assessments (full-field ERG, pattern ERG and VEP), the MOFO mfERG not only 
provides the retinal adaptation assessment but with topographic details. It aids in 
differentiating the early functional deterioration(s) at the middle and inner retina in 
diabetic retina. This result suggests potential retinal sites (middle and inner retina) for 
future pharmaceutical therapies. The MOFO mfERG is helpful in monitoring the 
disease progression before sight-threatening retinopathy supervenes. It may be useful 
in evaluating the effectiveness of the potential therapies [55].  
 
Conclusion 
DM can lead to early impaired adaptation in the retina before the presence of visible 
vascular lesions. With an increase in the severity of retinopathy, there is a more 
dramatic deterioration in the mfERG responses. Amplitudes of DC and IC 
components of the MOFO mfERG assessment appear to be better parameters than 
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implicit time measures in screening for diabetes without retinopathy. As far as the 
implicit time in MOFO mfERG is concerned, it is a better parameters for screening 
the diabetic retina with vascular lesions. The MOFO technique in mfERG provides a 
means of early detection of retinal anomalies in DM, and its findings also provide 
information about the severity of anomalies in the diabetic retina. 
 
 
 
Disclaimer: Presented in part of the July 2009 ISCEV meeting, Abano Terme, Padova, 
Italy. 
None of the authors have any proprietary interest. 
 
Acknowledgement: 
This study was supported by the Associated Fund (Research Postgraduate) from The 
Hong Kong Polytechnic University, Internal Research Grants (GU585, GU858) and 
the Niche Areas –Myopia Research (J-BB7P) and Glaucoma Research (J-BB76) from 
The Hong Kong Polytechnic University. Special thanks to Prof. Brian Brown for his 
valued opinions. 
20 
 
References 
1. LeRoith D, Taylor S, Olefsky J (2004) Diabetes mellitus - a fundamental and 
clinical text. Lippincott Williams and Wilkins 3rd Edition: 458-459 
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of 
diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 
27: 1047-1053 
3. Porta M, Bandello F (2002) Diabetic retinopathy - A clinical update. 
Diabetologia 45: 1617-1634 
4. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, 
Ferris FL, 3rd, Klein R (2003) Diabetic retinopathy. Diabetes Care 26: 
226-229 
5. Carmichael TR, Carp GI, Welsh ND, Kalk WJ (2005) Effective and accurate 
screening for diabetic retinopathy using a 60 degree mydriatic fundus camera. 
S Afr Med J 95: 57-61 
6. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK (1995) Methodology 
for Retinal Photography and Assessment of Diabetic-Retinopathy - the 
Eurodiab Iddm Complications Study. Diabetologia 38: 437-444 
7. Harding SP, Broadbent DM, Neoh C, White MC, Vora J (1995) Sensitivity and 
specificity of photography and direct ophthalmoscopy in screening for sight 
threatening eye disease: the Liverpool Diabetic Eye Study. BMJ 311: 
1131-1135 
8. Yamamoto S, Kamiyama M, Nitta K, Yamada T, Hayasaka S (1996) Selective 
reduction of the S cone electroretinogram in diabetes. Br J Ophthalmol 80: 
973-975 
21 
 
9. Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE (1997) Evidence 
for photoreceptor changes in patients with diabetic retinopathy. Invest 
Ophthalmol Vis Sci 38: 2355-2365 
10. Kizawa J, Machida S, Kobayashi T, Gotoh Y, Kurosaka D (2006) Changes of 
oscillatory potentials and photopic negative response in patients with early 
diabetic retinopathy. Jpn J Ophthalmol 50: 367-373 
11. Luu CD, Szental JA, Lee SY, Lavanya R, Wong TY (2010) Correlation 
between retinal oscillatory potentials and retinal vascular caliber in type 2 
diabetes. Invest Ophthalmol Vis Sci 51: 482-486 
12. Kern TS, Engerman RL (1995) Vascular lesions in diabetes are distributed 
non-uniformly within the retina. Exp Eye Res 60: 545-549 
13. Sutter EE, Tran D (1992) The field topography of ERG components in man--I. 
The photopic luminance response. Vision Res 32: 433-446 
14. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W (1997) Mapping of retinal 
function in diabetic retinopathy using the multifocal electroretinogram. Invest 
Ophthalmol Vis Sci 38: 2586-2596 
15. Shimada Y, Li Y, Bearse MA Jr, Sutter EE, Fung W (2001) Assessment of 
early retinal changes in diabetes using a new multifocal ERG protocol. Br J 
Ophthalmol 85: 414-419 
16. Fortune B, Schneck ME, Adams AJ (1999) Multifocal electroretinogram 
delays reveal local retinal dysfunction in early diabetic retinopathy. Invest 
Ophthalmol Vis Sci 40: 2638-2651 
17. Bearse MA Jr, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ (2004) 
Local multifocal oscillatory potential abnormalities in diabetes and early 
diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 3259-3265 
22 
 
18. Bronson-Castain KW, Bearse MA Jr, Neuville J, Jonasdottir S, King-Hooper B, 
Barez S, Schneck ME, Adams AJ (2009) Adolescents with type 2 diabetes 
early indications of focal retinal neuropathy, retinal thinning, and venular 
dilation. Retina 29: 618-626 
19. Sutter EE, Bearse MA Jr (1998) The retinal topography of local and lateral 
gain control mechanisms. Vision Science and Its Applications, OSA Technical 
Digest Series 1: 20-23 
20. Hood DC, Greenstein V, Frishman L, Holopigian K, Viswanathan S, Seiple W, 
Ahmed J, Robson JG (1999) Identifying inner retinal contributions to the 
human multifocal ERG. Vision Res 39: 2285-2291 
21. Sutter EE, Shimada Y, Li Y, Bearse MA Jr (1999) Mapping inner retinal 
function through enhancement of adaptation components in the M-ERG. 
Vision Science and Its Applications, OSA Technical Digest Series 1: 52-55 
22. Chu PH, Chan HH, Ng YF, Brown B, Siu AW, Beale BA, Gilger BC, Wong F 
(2008) Porcine global flash multifocal electroretinogram: possible 
mechanisms for the glaucomatous changes in contrast response function. 
Vision Res 48: 1726-1734 
23. Lung JC, Chan HH (2010) Effects of luminance combinations on the 
characteristics of the global flash multifocal electroretinogram (mfERG). 
Graefes Arch Clin Exp Ophthalmol 248: 1117-1125 
24. Bearse MA Jr, Han Y, Schneck M, Adams A (2003) Enhancement and 
mapping of inner retinal contributions to the human multifocal 
electroretinogram (mfERG). Invest Ophthalmol Vis Sci 44: ARVO E-abstract 
2696 
25. Wu S, Sutter EE (1995) A topographic study of oscillatory potentials in man. 
Vis Neurosci 12: 1013-1025 
23 
 
26. Sutter EE, Bearse MA Jr (1999) The optic nerve head component of the 
human ERG. Vision Res 39: 419-436 
27. Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading 
diabetic retinopathy from stereoscopic color fundus photographs--an extension 
of the modified Airlie House classification. ETDRS report number 10. 
Ophthalmology 98: 786-806 
28. Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus 
photographic risk factors for progression of diabetic retinopathy. ETDRS 
report number 12. Ophthalmology 98: 823-833 
29. Parisi V, Uccioli L (2001) Visual electrophysiological responses in persons 
with type 1 diabetes. Diabetes Metab Res Rev 17: 12-18 
30. Chen H, Zhang M, Huang S, Wu D (2008) The photopic negative response of 
flash ERG in nonproliferative diabetic retinopathy. Doc Ophthalmol 117: 
129-135 
31. Vadala M, Anastasi M, Lodato G, Cillino S (2002) Electroretinographic 
oscillatory potentials in insulin-dependent diabetes patients: A long-term 
follow-up. Acta Ophthalmol 80: 305-309 
32. Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L (1992) 
Oscillatory potentials, retinopathy, and long-term glucose control in 
insulin-dependent diabetes. Acta Ophthalmol 70: 705-712 
33. Simonsen SE (1980) The value of the oscillatory potential in selecting juvenile 
diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol 58: 
865-878 
34. Kurtenbach A, Langrova H, Zrenner E (2000) Multifocal oscillatory potentials 
in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci 41: 
3234-3241 
24 
 
35. Onozu H, Yamamoto S (2003) Oscillatory potentials of multifocal 
electroretinogram in diabetic retinopathy. Doc Ophthalmol 106: 327-332 
36. Shinoda K, Rejdak R, Schuettauf F, Blatsios G, Volker M, Tanimoto N, Olcay 
T, Gekeler F, Lehaci C, Naskar R, Zagorski Z, Zrenner E (2007) Early 
electroretinographic features of streptozotocin-induced diabetic retinopathy. 
Clin Experiment Ophthalmol 35: 847-854 
37. Alder VA, Cringle SJ, Constable IJ (1983) The retinal oxygen profile in cats. 
Invest Ophthalmol Vis Sci 24: 30-36 
38. Arden GB, Gunduz MK, Kurtenbach A, Volker M, Zrenner E, Gunduz SB, 
Kamis U, Ozturk BT, Okudan S (2010) A preliminary trial to determine 
whether prevention of dark adaptation affects the course of early diabetic 
retinopathy. Eye (Lond) 24: 1149-1155 
39. Linsenmeier RA (1986) Effects of light and darkness on oxygen distribution 
and consumption in the cat retina. J Gen Physiol 88: 521-542 
40. Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell 
DL, McLeod DS, Lutty GA (1998) Retinal hypoxia in long-term diabetic cats. 
Invest Ophthalmol Vis Sci 39: 1647-1657 
41. Wangsa-Wirawan ND, Linsenmeier RA (2003) Retinal oxygen: fundamental 
and clinical aspects. Arch Ophthalmol 121: 547-557 
42. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) 
Neural apoptosis in the retina during experimental and human diabetes. Early 
onset and effect of insulin. J Clin Invest 102: 783-791 
43. Kaneko M, Sugawara T, Tazawa Y (2000) Electrical responses from the inner 
retina of rats with streptozotocin-induced early diabetes mellitus. J Jpn 
Ophthalmol Soc 101: 775-778 
25 
 
44. Barber AJ (2003) A new view of diabetic retinopathy: a neurodegenerative 
disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 27: 283-290 
45. Greenstein VC, Hood DC, Ritch R, Steinberger D, Carr RE (1989) S (blue) 
cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. 
Invest Ophthalmol Vis Sci 30: 1732-1737 
46. Bearse MA Jr, Sutter EE (1999) Contrast dependence of multifocal ERG 
components. Vision Science and Its Applications, OSA Technical Digest 
Series 1: 24-27 
47. Chan HH, Ng YF, Chu PH (2011) Applications of the multifocal 
electroretinogram in the detection of glaucoma. Clin Exp Optom 94: 247-258 
48. Chu PH, Chan HH, Brown B (2006) Glaucoma detection is facilitated by 
luminance modulation of the global flash multifocal electroretinogram. Invest 
Ophthalmol Vis Sci 47: 929-937 
49. Schneck ME, Bearse MA Jr, Han Y, Barez S, Jacobsen C, Adams AJ (2004) 
Comparison of mfERG waveform components and implicit time measurement 
techniques for detecting functional change in early diabetic eye disease. Doc 
Ophthalmol 108: 223-230 
50. Bearse MA Jr, Han Y, Schneck ME, Adams AJ (2004) Retinal function in 
normal and diabetic eyes mapped with the slow flash multifocal 
electroretinogram. Invest Ophthalmol Vis Sci 45: 296-304 
51. Harrison WW, Bearse MA Jr, Ng JS, Jewell NP, Barez S, Burger D, Schneck 
ME, Adams AJ (2011) Multifocal electroretinograms predict onset of diabetic 
retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52: 
772-777 
52. Klemp K, Larsen M, Sander B, Vaag A, Brockhoff PB, Lund-Andersen H 
(2004) Effect of short-term hyperglycemia on multifocal electroretinogram in 
26 
 
diabetic patients without retinopathy. Invest Ophthalmol Vis Sci 45: 
3812-3819 
53. Masland RH (2001) Neuronal diversity in the retina. Curr Opin Neurobiol 11: 
431-436 
54. Zhou W, Rangaswamy N, Ktonas P, Frishman LJ (2007) Oscillatory potentials 
of the slow-sequence multifocal ERG in primates extracted using the 
Matching Pursuit method. Vision Res 47: 2021-2036 
55. Simo R, Hernandez C (2009) Advances in the medical treatment of diabetic 
retinopathy. Diabetes Care 32: 1556-1562 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
Tables 
Table 1. Correlation of the plasma glucose level and DM duration with the averaged 
MOFO mfERG parameters in diabetic subjects (* : p<0.05) 
Averaged 
MOFO 
parameters 
Contrast 
levels 
Plasma glucose level 
(mmol/L) 
n = 36 persons 
DM duration (ordinal 
parameters) 
n = 38 persons 
Pearson’s r p-value Spearman’s r p-value 
DCA_z 46% -0.136 0.427 0.012 0.943 
98% -0.054 0.752 -0.081 0.631 
ICA_z 46% 0.027 0.876 -0.022 0.897 
98% 0.082 0.636 -0.084 0.617 
DCIT_z 46% 0.162 0.345 -0.048 0.776 
98% 0.134 0.435 -0.028 0.868 
ICIT_z 46% 0.412 0.012 * 0.058 0.730 
98% 0.293 0.083 0.095 0.569 
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Table 2. Summary of the area-under-the-curve (AUC) for each MOFO parameter used 
in screening the regional samples with visible DR signs and screening the regional 
samples from DM groups (those with and without DR signs) 
MOFO 
parameters 
Contrast 
levels 
AUC for screening out the 
regional sample with visible 
DR signs (Group 2 - 4) 
AUC for screening out the 
regional sample from DM 
group (Group 1 - 4) 
DCA_z 46% 74.47% 70.89% 
98% 67.14% 69.28% 
ICA_z 46% 65.90% 58.20% 
98% 71.73% 69.10% 
DCIT_z 46% 56.45% 53.63% 
98% 76.59% 62.58% 
ICIT_z 46% 53.30% 56.67% 
98% 68.39% 61.31% 
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Figure Legends 
Fig. 1. Waveform of the MOFO response contains two main components: the direct 
component (DC) and induced component (IC). Note that the implicit time of DC is 
measured from the onset of the multifocal stimulus to the response peak of DC while 
the implicit time of IC is measured from the onset of the global flash (26.6ms) to the 
response peak of IC. 
 
Fig. 2. The multifocal stimuli pattern was mapped with the automated mosaic fundus 
photo (Each circle indicates the fundus photo taken at a particular gaze. There are 
totally 9 gazes, one central gaze and eight peripheral gazes, to form a mosaic fundus 
photo). Both were divided into 35 regions as in previous studies (about 2-3 hexagons 
were grouped as one region in the mfERG topography as indicated by the dark 
polygons). This figure illustrated the regional mfERG waveform of a diabetic patient 
with DR lesions at different locations. Those regional mfERG samples with DR (in 
RED lines) are compared with the averaged regional samples from the control group 
(in BLUE lines). 
 
Fig. 3. Comparison of the DC amplitude z-scores (DCA_z) for Groups 0 to 4 at high 
(98%) and low (46%) contrast levels (* : p<0.05 when compared with Group 0; † : 
p<0.05 when compared with Group 1) (Box plot: centre line – the mean; the edges of 
the box – ± 1 standard deviation; the edges of the vertical bars – range) 
 
Fig. 4. Comparison of IC amplitude z-scores (ICA_z) for Group 0 to 4 at high (98%) 
and low (46%) contrast levels (* : p<0.05 when compared to Group 0; † : p<0.05 
when compared to Group 1) (Box plot: centre line – the mean; the edges of the box – 
± 1 standard deviation; the edges of the vertical bars – range) 
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Fig. 5. Comparison of DC implicit time z-scores (DCIT_z) for Group 0 to 4 at high 
(98%) and low (46%) contrast levels (* : p<0.05 when compared to Group 0; † : 
p<0.05 when compared to Group 1) (Box plot: centre line – the mean; the edges of the 
box – ± 1 standard deviation; the edges of the vertical bars – range) 
 
Fig. 6. Comparison of IC implicit time z-scores (ICIT_z) for Group 0 to 4 at high 
(98%) and low (46%) contrast levels (* : p<0.05 when compared to Group 0; † : 
p<0.05 when compared to Group 1) (Box plot: centre line – the mean; the edges of the 
box – ± 1 standard deviation; the edges of the vertical bars – range) 
 
Table 1. Correlation of the plasma glucose level and DM duration with the averaged 
MOFO mfERG parameters in diabetic subjects (* : p<0.05) 
 
Table 2. Summary of the area-under-the-curve (AUC) for each MOFO parameter used 
in screening the regional samples with visible DR signs and screening the regional 
samples from DM groups (those with and without DR signs) 
